Literature DB >> 7610426

An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda.

P R Saunderson1.   

Abstract

Tuberculosis (TB) and AIDS are infections that are among the most feared of all diseases. Both have been widely discussed by the western media in recent months, for a variety of reasons, but it is the combination of the two diseases in an ever increasing number of patients that is causing concern to health planners and health economists. While AIDS is untreatable and prevention of further infection depends largely on changes in sexual behaviour, TB remains eminently treatable. Preventing the spread of TB depends on the effective treatment of active cases, taking 6-12 months, depending on the drugs used. In order to ensure completion of treatment, a programme of registering and following up patients is required. A number of different programme designs are considered and an analysis of both costs and consequences is attempted in order to find the most cost-effective alternative. Data from western Uganda for 1992 are used for the study and the implications of the findings for both Uganda and other African countries are discussed. It is concluded that a programme based on the ambulatory treatment of patients at their nearest health unit, whilst living at home, is the most cost-effective design, largely because of reduced costs to the patients themselves. Specific recommendations are made regarding the implementation of such a programme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610426     DOI: 10.1016/0277-9536(94)00240-t

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  14 in total

1.  The re-emergence of tuberculosis and its economic implications.

Authors:  H Sawert
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

2.  There's no such thing as a free TB diagnosis: Catastrophic TB costs in Urban Uganda.

Authors:  Rebecca L Walcott; Justin B Ingels; Phaedra S Corso; Sarah Zalwango; Christopher C Whalen; Juliet N Sekandi
Journal:  Glob Public Health       Date:  2020-02-06

3.  Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe.

Authors:  Julia R Kemp; Gillian Mann; Bertha Nhlema Simwaka; Felix Ml Salaniponi; Stephen Bertel Squire
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

4.  Cost of illness of tuberculosis in Penang, Malaysia.

Authors:  Elfatih Ibrahim Elamin; Mohamed Izham Mohamed Ibrahim; Syed Azhar Syed Sulaiman; Abdul Razak Muttalif
Journal:  Pharm World Sci       Date:  2008-01-18

5.  Occurrence of female genital tuberculosis among infertile women: a study from a tertiary maternal health care research centre in South India.

Authors:  V Bhanothu; J P Theophilus; P K Reddy; R Rozati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-04       Impact factor: 3.267

6.  Household costs of illness during different phases of tuberculosis treatment in Central Asia: a patient survey in Tajikistan.

Authors:  Raffael Ayé; Kaspar Wyss; Hanifa Abdualimova; Sadullo Saidaliev
Journal:  BMC Public Health       Date:  2010-01-18       Impact factor: 3.295

7.  Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia.

Authors:  Mengiste M Mesfin; James N Newell; Richard J Madeley; Tolib N Mirzoev; Israel G Tareke; Yohannes T Kifle; Amanuel Gessessew; John D Walley
Journal:  BMC Public Health       Date:  2010-03-30       Impact factor: 3.295

8.  Measuring Catastrophic Costs Due to Tuberculosis in Myanmar.

Authors:  Si Thu Aung; Aung Thu; Htin Lin Aung; Min Thu
Journal:  Trop Med Infect Dis       Date:  2021-07-14

9.  The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria.

Authors:  Nisser Ali Umar; Richard Fordham; Ibrahim Abubakar; Max Bachmann
Journal:  Cost Eff Resour Alloc       Date:  2012-05-11

Review 10.  Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.

Authors:  Devra M Barter; Stephen O Agboola; Megan B Murray; Till Bärnighausen
Journal:  BMC Public Health       Date:  2012-11-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.